Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 100.99 USD 0.01% Market Closed
Market Cap: $3.3B

Amedisys Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Amedisys Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Amedisys Inc
NASDAQ:AMED
Free Cash Flow
$234.2m
CAGR 3-Years
12%
CAGR 5-Years
-2%
CAGR 10-Years
13%
Quest Diagnostics Inc
NYSE:DGX
Free Cash Flow
$1.3B
CAGR 3-Years
15%
CAGR 5-Years
-9%
CAGR 10-Years
7%
CVS Health Corp
NYSE:CVS
Free Cash Flow
$7.8B
CAGR 3-Years
-17%
CAGR 5-Years
-10%
CAGR 10-Years
3%
Cigna Corp
NYSE:CI
Free Cash Flow
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Free Cash Flow
$1.2B
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
5%
Guardant Health Inc
NASDAQ:GH
Free Cash Flow
-$233.1m
CAGR 3-Years
16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
No Stocks Found

Amedisys Inc
Glance View

Amedisys Inc., headquartered in Baton Rouge, Louisiana, has crafted its narrative at the forefront of America's healthcare sector, by focusing squarely on providing quality home health and hospice services. Established in 1982, the company has steadily expanded its reach, now operating in more than 30 states with a strong network of healthcare professionals dedicated to delivering comprehensive care at the patient's doorstep. Amedisys identifies the growing preference for home-based care among patients and leverages this trend by offering services in home health, hospice, and personal care. This strategic focus aligns with the nationwide shift towards value-based care, where healthcare providers are rewarded for the quality and effectiveness of care given to patients rather than volume. The company's financial engine thrives on two primary service lines: home health and hospice care. Home health services are Amedisys’s backbone, generating revenue by providing skilled medical care and support services at home to patients recovering from illnesses, surgeries, or those managing chronic diseases. Their clinicians, comprising nurses and therapists, work closely with patients to ensure a personalized care plan tailored to individual needs. Hospice care, on the other hand, caters to terminally ill patients, offering support that prioritizes comfort and quality of life in their final days. By understanding the intricacies of Medicare, Medicaid, and private insurance billing, Amedisys efficiently navigates reimbursement pathways, ensuring steady cash flow while aligning with regulatory requirements. This operational model not only feeds into Amedisys's financial health but also solidifies its role as a crucial player in the evolving landscape of at-home healthcare services.

AMED Intrinsic Value
106.26 USD
Undervaluation 5%
Intrinsic Value
Price $100.99

See Also

What is Amedisys Inc's Free Cash Flow?
Free Cash Flow
234.2m USD

Based on the financial report for Jun 30, 2025, Amedisys Inc's Free Cash Flow amounts to 234.2m USD.

What is Amedisys Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
13%

Over the last year, the Free Cash Flow growth was 165%. The average annual Free Cash Flow growth rates for Amedisys Inc have been 12% over the past three years , -2% over the past five years , and 13% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett